BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
0.0026 B
Last period Revenue ,USD
What is Revenue ?
Revenue is the total amount of money received by the company from the sale of its goods and services. The presence of revenue is a necessary condition for evaluating a company by Eyestock Rating.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
Revenue is the total amount of money received by the company from the sale of its goods and services. The presence of revenue is a necessary condition for evaluating a company by Eyestock Rating.
BioNexus Gene`s Revenue for the period ended 2023-09-30 is 0.0026 B USD
